Lilly confirmed it would buy a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.

Title: Lilly backs precision medicine start-up’s $65 million raise. Author: * Send Email To: Enter the valid email address. * Add Comment To Email: Enter the comment.

Title: Lilly-partnered start-up raises $65 million for RNA-targeting drugs. Author: * Send Email To: Enter the valid email address. * Add Comment To Email: Enter the comment.

If Eli Lilly presents strong data, the stock could be set to rally and potentially be on a path to reaching new highs. Should ...

Eli Lilly, the company that makes the blockbuster weight loss treatment Zepbound, will start studying its obesity products as treatments for alcohol and drug addiction, making it the first major ...

Eli Lilly and Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors like alcohol abuse, smoking and drug addiction, Chief ...

To earn $500 monthly from Eli Lilly, start with a yearly target of $6,000 ($500 x 12 months). Next, we take this amount and divide it by Eli Lilly's $5.20 dividend: $6,000 / $5.20 = 1,154 shares.